annual accounts payable:
$77.87M-$24.88M(-24.22%)Summary
- As of today (May 21, 2025), JAZZ annual accounts payable is $77.87 million, with the most recent change of -$24.88 million (-24.22%) on December 31, 2024.
- During the last 3 years, JAZZ annual accounts payable has fallen by -$22.43 million (-22.36%).
- JAZZ annual accounts payable is now -24.22% below its all-time high of $102.75 million, reached on December 31, 2023.
Performance
JAZZ Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$95.93M+$18.06M(+23.19%)Summary
- As of today (May 21, 2025), JAZZ quarterly accounts payable is $95.93 million, with the most recent change of +$18.06 million (+23.19%) on March 1, 2025.
- Over the past year, JAZZ quarterly accounts payable has increased by +$14.95 million (+18.47%).
- JAZZ quarterly accounts payable is now -23.53% below its all-time high of $125.45 million, reached on March 31, 2023.
Performance
JAZZ quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
JAZZ Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.2% | +18.5% |
| 3 y3 years | -22.4% | +30.8% |
| 5 y5 years | +70.3% | +44.7% |
JAZZ Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.2% | at low | -23.5% | +30.8% |
| 5 y | 5-year | -24.2% | +189.0% | -23.5% | +256.0% |
| alltime | all time | -24.2% | +3508.4% | -23.5% | +4345.3% |
JAZZ Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $95.93M(+23.2%) |
| Dec 2024 | $77.87M(-24.2%) | $77.87M(-8.8%) |
| Sep 2024 | - | $85.42M(-12.0%) |
| Jun 2024 | - | $97.10M(+19.9%) |
| Mar 2024 | - | $80.98M(-21.2%) |
| Dec 2023 | $102.75M(+13.2%) | $102.75M(-6.5%) |
| Sep 2023 | - | $109.85M(+11.6%) |
| Jun 2023 | - | $98.43M(-21.5%) |
| Mar 2023 | - | $125.45M(+38.2%) |
| Dec 2022 | $90.76M(-9.5%) | $90.76M(-11.2%) |
| Sep 2022 | - | $102.25M(+37.9%) |
| Jun 2022 | - | $74.16M(+1.1%) |
| Mar 2022 | - | $73.34M(-26.9%) |
| Dec 2021 | $100.30M(+272.2%) | $100.30M(+57.2%) |
| Sep 2021 | - | $63.81M(-1.6%) |
| Jun 2021 | - | $64.83M(-16.6%) |
| Mar 2021 | - | $77.74M(+188.5%) |
| Dec 2020 | $26.95M(-41.1%) | $26.95M(-59.8%) |
| Sep 2020 | - | $67.06M(+34.0%) |
| Jun 2020 | - | $50.04M(-24.5%) |
| Mar 2020 | - | $66.31M(+45.0%) |
| Dec 2019 | $45.73M(+12.6%) | $45.73M(-34.8%) |
| Sep 2019 | - | $70.10M(-14.7%) |
| Jun 2019 | - | $82.22M(+92.7%) |
| Mar 2019 | - | $42.67M(+5.1%) |
| Dec 2018 | $40.60M(+66.6%) | $40.60M(+8.6%) |
| Sep 2018 | - | $37.37M(+19.1%) |
| Jun 2018 | - | $31.38M(-33.1%) |
| Mar 2018 | - | $46.93M(+92.6%) |
| Dec 2017 | $24.37M(+8.7%) | $24.37M(-18.7%) |
| Sep 2017 | - | $29.97M(+5.1%) |
| Jun 2017 | - | $28.53M(-2.1%) |
| Mar 2017 | - | $29.14M(+30.0%) |
| Dec 2016 | $22.41M(+2.8%) | $22.41M(+27.2%) |
| Sep 2016 | - | $17.63M(-37.9%) |
| Jun 2016 | - | $28.41M(-12.9%) |
| Mar 2016 | - | $32.62M(+49.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $21.81M(-13.2%) | $21.81M(-25.1%) |
| Sep 2015 | - | $29.12M(+10.3%) |
| Jun 2015 | - | $26.41M(-3.3%) |
| Mar 2015 | - | $27.32M(+8.7%) |
| Dec 2014 | $25.13M(+19.6%) | $25.13M(-15.3%) |
| Sep 2014 | - | $29.67M(-8.9%) |
| Jun 2014 | - | $32.55M(-55.1%) |
| Mar 2014 | - | $72.54M(+245.3%) |
| Dec 2013 | $21.00M(+32.2%) | $21.00M(-6.4%) |
| Sep 2013 | - | $22.43M(+10.1%) |
| Jun 2013 | - | $20.37M(-35.6%) |
| Mar 2013 | - | $31.63M(+99.1%) |
| Dec 2012 | $15.89M(+209.7%) | $15.89M(-22.6%) |
| Sep 2012 | - | $20.54M(-40.5%) |
| Jun 2012 | - | $34.51M(+152.1%) |
| Mar 2012 | - | $13.69M(+166.9%) |
| Dec 2011 | $5.13M(+68.2%) | $5.13M(-39.4%) |
| Sep 2011 | - | $8.46M(+81.4%) |
| Jun 2011 | - | $4.67M(+27.9%) |
| Mar 2011 | - | $3.65M(+19.6%) |
| Dec 2010 | $3.05M(+41.3%) | $3.05M(-52.4%) |
| Jun 2010 | - | $6.40M(+64.8%) |
| Mar 2010 | - | $3.88M(+80.0%) |
| Dec 2009 | $2.16M(-62.4%) | $2.16M(-58.8%) |
| Sep 2009 | - | $5.24M(+28.6%) |
| Jun 2009 | - | $4.07M(-10.5%) |
| Mar 2009 | - | $4.55M(-20.6%) |
| Dec 2008 | $5.74M(+100.8%) | $5.74M(-13.3%) |
| Sep 2008 | - | $6.61M(-22.4%) |
| Jun 2008 | - | $8.52M(-4.4%) |
| Mar 2008 | - | $8.91M(+212.1%) |
| Dec 2007 | $2.86M(-47.5%) | $2.86M(-0.6%) |
| Sep 2007 | - | $2.87M(-32.7%) |
| Jun 2007 | - | $4.27M(+35.7%) |
| Mar 2007 | - | $3.15M(-42.2%) |
| Dec 2006 | $5.44M(+13.7%) | $5.44M(+13.7%) |
| Dec 2005 | $4.79M | $4.79M |
FAQ
- What is Jazz Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual accounts payable year-on-year change?
- What is Jazz Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly accounts payable year-on-year change?
What is Jazz Pharmaceuticals annual accounts payable?
The current annual accounts payable of JAZZ is $77.87M
What is the all time high annual accounts payable for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual accounts payable is $102.75M
What is Jazz Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, JAZZ annual accounts payable has changed by -$24.88M (-24.22%)
What is Jazz Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of JAZZ is $95.93M
What is the all time high quarterly accounts payable for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly accounts payable is $125.45M
What is Jazz Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, JAZZ quarterly accounts payable has changed by +$14.95M (+18.47%)